Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Breast Cancer

Treatments: Procedure: new software sequences, FIESTA and Vibrant-DE and IDEAL

Study type: Interventional

Funder types: Other

Identifiers

NCT00579800

07-091

Details and patient eligibility

About

The purpose of this study is to evaluate new computer software on breast magnetic resonance imaging (MRI). The information from this study may help doctors and scientists develop better ways to find breast cancer, and may help future patents with cancer.

Enrollment: 76 patients

Sex: Female

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female patients over the age of 21 undergoing a diagnostic Breast MRI.

Exclusion criteria

• Patients who would be normally excluded from undergoing an MRI examination
• Patients with a pacemaker, aneurysm clip or any other condition that would warrant avoidance of a strong magnetic field.
• Patients under the age of 21.
• Female patients who are pregnant.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

76 participants in 1 patient group

women undergoing routine breast MRI

Experimental group

Description:

Conventional images will be taken using the standard sequences consisting of T2-weighted imaging and T1-weighted imaging before and after contrast; these will be used for the diagnostic examination. FIESTA will be performed on 50 patients, while Vibrant-DE and IDEAL will be performed on the other 50 patients.

Treatment:

Procedure: new software sequences, FIESTA and Vibrant-DE and IDEAL